In conclusion, this study demonstrated that the TLR4/NF-κB/NLRP3 pathway is involved in the anti-inflammatory and anti-myocardial ischemia/reperfusion injury (MIRI) properties of tilianin. The gene discussed is NLRP3; the disease is myocardial ischemia.